Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–46 of 46 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patching Clear all

Conditions: Cerebrospinal Fluid Leaks
Interventions: TISSEEL; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Amblyopia
Interventions: Patch-free occlusion therapy, Adhesive patch; Device
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 3 Years to 12 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Exotropia
Interventions: occlusion treatment; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 12 Months to 10 Years
Enrollment: 611 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Fullerton, California • Rochester, Minnesota

Conditions: Amblyopia
Interventions: Eye patch, spectacles, atropine; Device · Drug
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 7 Years to 17 Years
Enrollment: 507 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 3
States / cities: Baltimore, Maryland • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Amblyopia
Interventions: Asynchronous 3D movies, Patching; Device
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 3 Years to 7 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Amblyopia
Interventions: Donepezil, Patching; Drug · Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2021
U.S. locations: 3
States / cities: Boston, Massachusetts • Waltham, Massachusetts • Weymouth, Massachusetts

Conditions: Amblyopia
Interventions: Patching, Near activities, Active vision therapy, Control vision therapy; Device · Procedure
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 7 Years to 12 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 7
States / cities: Birmingham, Alabama • Miami, Florida • Bloomington, Indiana + 4 more

Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
Interventions: nepafenac 0.3% suspension (Ilevro; Alcon, Fort Worth, TX), Theratears tear drop, (Akron, Ann 111 Arbor, MI), patching; Drug · Other
Lead sponsor: The New York Eye & Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Asthma
Interventions: Integrated Pest Management; Other
Lead sponsor: New York City Department of Health and Mental Hygiene; Government
Eligibility: 5 Years to 12 Years
Enrollment: 384 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: Amblyopia
Interventions: Binocular video games, Patching of the sound eye; Device
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 4 Years to 12 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 5
States / cities: Gainesville, Florida • Maitland, Florida • Chicago, Illinois + 2 more

Conditions: Amblyopia, Strabismus
Interventions: Patching therapy, Glasses; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 6 Months to 90 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Amblyopia
Interventions: Patching, Glasses; Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 13 Years
Enrollment: 544 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 68
States / cities: Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 57 more

Conditions: Amblyopia, Anisometropia, Strabismus
Interventions: Dichoptic therapy, Patching therapy, Dioptic (non-dichoptic) therapy; Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 15 Years to 40 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Amblyopia
Interventions: Eye Patch, Near activities, Distance activities; Device · Procedure
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 6 Years
Enrollment: 425 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 2
States / cities: Bloomington, Indiana • Rochester, Minnesota

Conditions: Amblyopia
Interventions: Caffeine; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 7 Years to 13 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Amblyopia
Interventions: Bangerter filters, Patching, Near activities; Device · Procedure
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 9 Years
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Amblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic, Amblyopia Strabismic
Interventions: Valproate, Placebo, Patch; Drug · Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 17 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Amblyopia
Interventions: Docosahexaenoic Acid, Placebo Oral Tablet; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 3 Years to 17 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Amblyopia
Interventions: Patching, Atropine; Device · Drug
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 9 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Amblyopia
Interventions: Eye patch; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 7 Years
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2002
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Amblyopia
Interventions: Physical Exercise in addition to Patching; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 5 Years to 16 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Amblyopia
Interventions: 4-hour AmblyZ glasses, 12-hour AmblyZ glasses, 2-hour patching, 6-hour patching; Device
Lead sponsor: Indiana University; Other
Eligibility: 3 Years to 8 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Search by objective public record fields.

A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment

Patch-free Occlusion Therapy

Observation Versus Occlusion Therapy for Intermittent Exotropia

An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old

Video Treatment for Amblyopia

Treatment of Residual Amblyopia With Donepezil

Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia

Post Intravitreal Injection Topical NSAID vs. Patching

Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma

Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Dichoptic Virtual Reality Therapy for Amblyopia in Adults

Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old

Caffeine in Amblyopia Study

Full-time Bangerter Filters Versus Part-time Daily Patching for Moderate Amblyopia in Children

Valproate for the Treatment of Residual Amblyopia

Docosahexaenoic Acid (DHA) Supplementation in Amblyopia

Combined Patching-Atropine for Residual Amblyopia

Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia

Augmenting Patching Treatment for Amblyopia With Physical Exercise

Comparison of AmblyzTM Glasses and Patching for Amblyopia